Cargando…
An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
Understanding, predicting, and minimizing the immunogenicity of peptide-based therapeutics are of paramount importance for ensuring the safety and efficacy of these products. The so-called anti-drug antibodies (ADA) may have various clinical consequences, including but not limited to the alteration...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707785/ https://www.ncbi.nlm.nih.gov/pubmed/34946542 http://dx.doi.org/10.3390/molecules26247461 |
_version_ | 1784622522651639808 |
---|---|
author | Holley, Claire K. Cedrone, Edward Donohue, Duncan Neun, Barry W. Verthelyi, Daniela Pang, Eric S. Dobrovolskaia, Marina A. |
author_facet | Holley, Claire K. Cedrone, Edward Donohue, Duncan Neun, Barry W. Verthelyi, Daniela Pang, Eric S. Dobrovolskaia, Marina A. |
author_sort | Holley, Claire K. |
collection | PubMed |
description | Understanding, predicting, and minimizing the immunogenicity of peptide-based therapeutics are of paramount importance for ensuring the safety and efficacy of these products. The so-called anti-drug antibodies (ADA) may have various clinical consequences, including but not limited to the alteration in the product’s distribution, biological activity, and clearance profiles. The immunogenicity of biotherapeutics can be influenced by immunostimulation triggered by the presence of innate immune response modulating impurities (IIRMIs) inadvertently introduced during the manufacturing process. Herein, we evaluate the applicability of several in vitro assays (i.e., complement activation, leukocyte proliferation, and cytokine secretion) for the screening of innate immune responses induced by ten common IIRMIs (Bacillus subtilis flagellin, FSL-1, zymosan, ODN2006, poly(I:C) HMW, poly(I:C) LMW, CLO75, MDP, ODN2216, and Escherichia coli O111:B4 LPS), and a model biotherapeutic Forteo™ (teriparatide). Our study identifies cytokine secretion from healthy human donor peripheral blood mononuclear cells (PBMC) as a sensitive method for the in vitro monitoring of innate immune responses to individual IIRMIs and teriparatide (TP). We identify signature cytokines, evaluate both broad and narrow multiplex cytokine panels, and discuss how the assay logistics influence the performance of this in vitro assay. |
format | Online Article Text |
id | pubmed-8707785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87077852021-12-25 An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide Holley, Claire K. Cedrone, Edward Donohue, Duncan Neun, Barry W. Verthelyi, Daniela Pang, Eric S. Dobrovolskaia, Marina A. Molecules Article Understanding, predicting, and minimizing the immunogenicity of peptide-based therapeutics are of paramount importance for ensuring the safety and efficacy of these products. The so-called anti-drug antibodies (ADA) may have various clinical consequences, including but not limited to the alteration in the product’s distribution, biological activity, and clearance profiles. The immunogenicity of biotherapeutics can be influenced by immunostimulation triggered by the presence of innate immune response modulating impurities (IIRMIs) inadvertently introduced during the manufacturing process. Herein, we evaluate the applicability of several in vitro assays (i.e., complement activation, leukocyte proliferation, and cytokine secretion) for the screening of innate immune responses induced by ten common IIRMIs (Bacillus subtilis flagellin, FSL-1, zymosan, ODN2006, poly(I:C) HMW, poly(I:C) LMW, CLO75, MDP, ODN2216, and Escherichia coli O111:B4 LPS), and a model biotherapeutic Forteo™ (teriparatide). Our study identifies cytokine secretion from healthy human donor peripheral blood mononuclear cells (PBMC) as a sensitive method for the in vitro monitoring of innate immune responses to individual IIRMIs and teriparatide (TP). We identify signature cytokines, evaluate both broad and narrow multiplex cytokine panels, and discuss how the assay logistics influence the performance of this in vitro assay. MDPI 2021-12-09 /pmc/articles/PMC8707785/ /pubmed/34946542 http://dx.doi.org/10.3390/molecules26247461 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Holley, Claire K. Cedrone, Edward Donohue, Duncan Neun, Barry W. Verthelyi, Daniela Pang, Eric S. Dobrovolskaia, Marina A. An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title | An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title_full | An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title_fullStr | An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title_full_unstemmed | An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title_short | An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide |
title_sort | in vitro assessment of immunostimulatory responses to ten model innate immune response modulating impurities (iirmis) and peptide drug product, teriparatide |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707785/ https://www.ncbi.nlm.nih.gov/pubmed/34946542 http://dx.doi.org/10.3390/molecules26247461 |
work_keys_str_mv | AT holleyclairek aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT cedroneedward aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT donohueduncan aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT neunbarryw aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT verthelyidaniela aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT pangerics aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT dobrovolskaiamarinaa aninvitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT holleyclairek invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT cedroneedward invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT donohueduncan invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT neunbarryw invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT verthelyidaniela invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT pangerics invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide AT dobrovolskaiamarinaa invitroassessmentofimmunostimulatoryresponsestotenmodelinnateimmuneresponsemodulatingimpuritiesiirmisandpeptidedrugproductteriparatide |